BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 1167568)

  • 1. Impaired macrophage function in Friend virus leukemia: restoration by statolon.
    Levy MH; Wheelock EF
    J Immunol; 1975 Mar; 114(3):962-5. PubMed ID: 1167568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depression of humoral immunity to sheep erythrocytes in vitro by Friend virus leukemic spleen cells: induction of resistance by statolon.
    Weislow OS; Wheelock EF
    J Immunol; 1975 Jan; 114(1 Pt 1):211-5. PubMed ID: 1089711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of extablished Friend virus leukemia by statolon: potentiation of statolon's leukemosuppressive activity by chlorite-oxidized oxyamylose.
    Weislow OS; Wheelock EF
    Infect Immun; 1975 Jan; 11(1):129-36. PubMed ID: 1090523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of silica to identify host mechanisms involved in suppression of established Friend virus leukemia.
    Wirth JJ; Levy MH; Wheelock EF
    J Immunol; 1976 Dec; 117(6):2124-30. PubMed ID: 186537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spontaneous regression of Friend virus-induced erythroleukemia. III. The role of macrophages in regression.
    Marcelletti J; Furmanski P
    J Immunol; 1978 Jan; 120(1):1-8. PubMed ID: 203629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of macrophages in suppression of established Friend virus leukemia.
    Levy MH; Wheelock EF
    J Reticuloendothel Soc; 1976 Sep; 20(3):243-54. PubMed ID: 1068297
    [No Abstract]   [Full Text] [Related]  

  • 7. Restored immune and nonimmune functions in Friend virus leukemic mice treated with statolon.
    Wheelock EF; Toy ST; Weislow OS; Levy MH
    Prog Exp Tumor Res; 1974; 19():369-89. PubMed ID: 4612609
    [No Abstract]   [Full Text] [Related]  

  • 8. Suppression of established Friend virus leukemia by statolon. 3. Development of FV-leukemogenic and FV-immunogenic activities in bloods, spleens, and lymph nodes.
    Wheelock EF; Caroline NL; Moore RD
    J Natl Cancer Inst; 1971 Apr; 46(4):797-802. PubMed ID: 5103314
    [No Abstract]   [Full Text] [Related]  

  • 9. [Phagocytic function of the macrophages in leukemic animals].
    Fan FF
    Eksp Med Morfol; 1976; 15(2):83-8. PubMed ID: 1278085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of in vivo Friend leukemia virus infection on levels of serum thymic factors and on selected T-cell functions in mice.
    Tonietti G; Rossi GB; Del Gobbo V; Accinni L; Ranucci A; Titti F; Premrov MG; Garaci E
    Cancer Res; 1983 Sep; 43(9):4355-63. PubMed ID: 6347370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrophage-induced reversal of immunosuppression by leukemia viruses.
    Specter SC; Bendinelli M; Ceglowski WS; Friedman H
    Fed Proc; 1978 Jan; 37(1):97-101. PubMed ID: 201505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrophage-mediated natural cytotoxicity of dimethyl sulfoxide-treated Friend erythroleukemia cells.
    Hsu KH; Friedman H
    J Natl Cancer Inst; 1985 Jul; 75(1):105-10. PubMed ID: 3859684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of macrophage reversal of Friend erythroleukemia: macrophage regulation of normal and leukemic erythropoiesis.
    Johnson CS; Thurlow SM; Marcelletti JF; Furmanski P
    Cancer Res; 1986 Aug; 46(8):3896-902. PubMed ID: 3460693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of established Friend virus leukemia by statolon. V. Reversal of virus-induced immunodepression to sheep erythrocytes.
    Weislow OS; Friedman H; Wheelock EF
    Proc Soc Exp Biol Med; 1973 Feb; 142(2):401-5. PubMed ID: 4570037
    [No Abstract]   [Full Text] [Related]  

  • 15. Cellular and serum involvement in protection against Friend leukemia virus.
    Schuller GB; Morahan PS
    Cancer Res; 1977 Nov; 37(11):4064-9. PubMed ID: 908040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon and friend virus-induced leukemic cells: in vivo and in vitro interactions.
    Rossi GB; Matarese GP; Marchegiani M; Grappelli C
    Boll Ist Sieroter Milan; 1974; 53(4):538-42. PubMed ID: 4451582
    [No Abstract]   [Full Text] [Related]  

  • 17. Suppression of established Friend virus leukemia by statolon. IV. Role of humoral antibody in the development of a dormant infection.
    Wheelock EF; Toy ST; Caroline NL; Sibal LR; Fink MA; Beverley PC; Allison AC
    J Natl Cancer Inst; 1972 Mar; 48(3):665-73. PubMed ID: 5062046
    [No Abstract]   [Full Text] [Related]  

  • 18. Absence of macrophage involvement in the passive serum therapy of Friend leukemia virus-induced disease.
    Collins JJ; Snyderman R
    Cancer Res; 1980 Mar; 40(3):557-62. PubMed ID: 6258783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of Friend leukemia virus and spleen focus-forming virus-specific sequences in erythroid bursts and granulocyte-macrophage colonies from spleen and marrow of mice infected with Friend leukemia virus.
    Colletta G; Di Fiore PP; Fusco A; Lettieri F; Covelli A; Peschle C
    Cancer Res; 1983 Feb; 43(2):598-603. PubMed ID: 6293700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Function and role of peritoneal macrophages in experimental leukaemia.
    Thi Phi Phi P; Nedelkova M; Serafimov-Dimitrov V
    Haematologia (Budap); 1981; 14(1):29-38. PubMed ID: 7250816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.